These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 22471526)

  • 1. Confirmation of an epilepsy modifier locus on mouse chromosome 11 and candidate gene analysis by RNA-Seq.
    Hawkins NA; Kearney JA
    Genes Brain Behav; 2012 Jun; 11(4):452-60. PubMed ID: 22471526
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cacna1g is a genetic modifier of epilepsy caused by mutation of voltage-gated sodium channel Scn2a.
    Calhoun JD; Hawkins NA; Zachwieja NJ; Kearney JA
    Epilepsia; 2016 Jun; 57(6):e103-7. PubMed ID: 27112236
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hlf is a genetic modifier of epilepsy caused by voltage-gated sodium channel mutations.
    Hawkins NA; Kearney JA
    Epilepsy Res; 2016 Jan; 119():20-3. PubMed ID: 26656780
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fine mapping of an epilepsy modifier gene on mouse Chromosome 19.
    Bergren SK; Rutter ED; Kearney JA
    Mamm Genome; 2009 Jun; 20(6):359-66. PubMed ID: 19513789
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neuronal voltage-gated ion channels are genetic modifiers of generalized epilepsy with febrile seizures plus.
    Hawkins NA; Martin MS; Frankel WN; Kearney JA; Escayg A
    Neurobiol Dis; 2011 Mar; 41(3):655-60. PubMed ID: 21156207
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic modifiers affecting severity of epilepsy caused by mutation of sodium channel Scn2a.
    Bergren SK; Chen S; Galecki A; Kearney JA
    Mamm Genome; 2005 Sep; 16(9):683-90. PubMed ID: 16245025
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Severe epilepsy resulting from genetic interaction between Scn2a and Kcnq2.
    Kearney JA; Yang Y; Beyer B; Bergren SK; Claes L; Dejonghe P; Frankel WN
    Hum Mol Genet; 2006 Mar; 15(6):1043-8. PubMed ID: 16464983
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fine Mapping of a Dravet Syndrome Modifier Locus on Mouse Chromosome 5 and Candidate Gene Analysis by RNA-Seq.
    Hawkins NA; Zachwieja NJ; Miller AR; Anderson LL; Kearney JA
    PLoS Genet; 2016 Oct; 12(10):e1006398. PubMed ID: 27768696
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CaMKII modulates sodium current in neurons from epileptic
    Thompson CH; Hawkins NA; Kearney JA; George AL
    Proc Natl Acad Sci U S A; 2017 Feb; 114(7):1696-1701. PubMed ID: 28137877
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mapping genetic modifiers of survival in a mouse model of Dravet syndrome.
    Miller AR; Hawkins NA; McCollom CE; Kearney JA
    Genes Brain Behav; 2014 Feb; 13(2):163-72. PubMed ID: 24152123
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fine mapping and candidate gene analysis of a dravet syndrome modifier locus on mouse chromosome 11.
    Kearney JA; Copeland-Hardin LD; Duarte S; Zachwieja NA; Eckart-Frank IK; Hawkins NA
    Mamm Genome; 2022 Dec; 33(4):565-574. PubMed ID: 35606653
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Na channel gene mutations in epilepsy--the functional consequences.
    Yamakawa K
    Epilepsy Res; 2006 Aug; 70 Suppl 1():S218-22. PubMed ID: 16806834
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cacna1g is a genetic modifier of epilepsy in a mouse model of Dravet syndrome.
    Calhoun JD; Hawkins NA; Zachwieja NJ; Kearney JA
    Epilepsia; 2017 Aug; 58(8):e111-e115. PubMed ID: 28556246
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The voltage-gated sodium channel Scn8a is a genetic modifier of severe myoclonic epilepsy of infancy.
    Martin MS; Tang B; Papale LA; Yu FH; Catterall WA; Escayg A
    Hum Mol Genet; 2007 Dec; 16(23):2892-9. PubMed ID: 17881658
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Generalized epilepsy with febrile seizures plus (GEFS+): clinical spectrum in seven Italian families unrelated to SCN1A, SCN1B, and GABRG2 gene mutations.
    Bonanni P; Malcarne M; Moro F; Veggiotti P; Buti D; Ferrari AR; Parrini E; Mei D; Volzone A; Zara F; Heron SE; Bordo L; Marini C; Guerrini R
    Epilepsia; 2004 Feb; 45(2):149-58. PubMed ID: 14738422
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A gain-of-function mutation in the sodium channel gene Scn2a results in seizures and behavioral abnormalities.
    Kearney JA; Plummer NW; Smith MR; Kapur J; Cummins TR; Waxman SG; Goldin AL; Meisler MH
    Neuroscience; 2001; 102(2):307-17. PubMed ID: 11166117
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A role of SCN9A in human epilepsies, as a cause of febrile seizures and as a potential modifier of Dravet syndrome.
    Singh NA; Pappas C; Dahle EJ; Claes LR; Pruess TH; De Jonghe P; Thompson J; Dixon M; Gurnett C; Peiffer A; White HS; Filloux F; Leppert MF
    PLoS Genet; 2009 Sep; 5(9):e1000649. PubMed ID: 19763161
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Voltage-gated potassium channel KCNV2 (Kv8.2) contributes to epilepsy susceptibility.
    Jorge BS; Campbell CM; Miller AR; Rutter ED; Gurnett CA; Vanoye CG; George AL; Kearney JA
    Proc Natl Acad Sci U S A; 2011 Mar; 108(13):5443-8. PubMed ID: 21402906
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Channelopathies as a genetic cause of epilepsy.
    Mulley JC; Scheffer IE; Petrou S; Berkovic SF
    Curr Opin Neurol; 2003 Apr; 16(2):171-6. PubMed ID: 12644745
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sodium channel dysfunction in intractable childhood epilepsy with generalized tonic-clonic seizures.
    Rhodes TH; Vanoye CG; Ohmori I; Ogiwara I; Yamakawa K; George AL
    J Physiol; 2005 Dec; 569(Pt 2):433-45. PubMed ID: 16210358
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.